I think the biggest problem is the folks at WotC aren't really doing a lot of their own marketing. They seem to be depending mostly on word of mouth between players of D&D, fan sites like this one, and their website.
We have a demo of the game or the ability to try it out with the PHB lite and the monsters people have brought back from D&DXP and picked from other sources but that was done by the community and not WotC for the most part. It would of been nice of the people at WotC to let us have the Escape from Sembia and Scalegloom hall stuff from D&DXP to really try out the game.
I'd also like to see some ad's coming out sometime soon but they have already decided in an article or podcast, I can't remember where, that their target audience for the first 6 months to a year is the people who already play D&D. After that initial period they planed on going after folks who've never played the game or are on the fringe.
Based on that using word of mouth, internet fan sites, and their site it seems like a pretty good strategy. It's fairly efficient as far as cost to number of people hearing about the product are concerened.
We have a demo of the game or the ability to try it out with the PHB lite and the monsters people have brought back from D&DXP and picked from other sources but that was done by the community and not WotC for the most part. It would of been nice of the people at WotC to let us have the Escape from Sembia and Scalegloom hall stuff from D&DXP to really try out the game.
I'd also like to see some ad's coming out sometime soon but they have already decided in an article or podcast, I can't remember where, that their target audience for the first 6 months to a year is the people who already play D&D. After that initial period they planed on going after folks who've never played the game or are on the fringe.
Based on that using word of mouth, internet fan sites, and their site it seems like a pretty good strategy. It's fairly efficient as far as cost to number of people hearing about the product are concerened.